These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New approaches to the pharmacological management of generalized anxiety disorder. Buoli M; Caldiroli A; Caletti E; Paoli RA; Altamura AC Expert Opin Pharmacother; 2013 Feb; 14(2):175-84. PubMed ID: 23282069 [TBL] [Abstract][Full Text] [Related]
8. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Tassone DM; Boyce E; Guyer J; Nuzum D Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review. Samuel M; Zimovetz EA; Gabriel Z; Beard SM Int Clin Psychopharmacol; 2011 Mar; 26(2):63-8. PubMed ID: 21088608 [TBL] [Abstract][Full Text] [Related]
10. Pregabalin for the treatment of generalized anxiety disorder. Wensel TM; Powe KW; Cates ME Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
12. Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression. Hassan AK; Farmer KC; Brahm NC; Neas BR Int J Clin Pharm; 2016 Apr; 38(2):429-37. PubMed ID: 26935957 [TBL] [Abstract][Full Text] [Related]
14. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Bandelow B; Wedekind D; Leon T Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384 [TBL] [Abstract][Full Text] [Related]
15. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. Pignon B; Tezenas du Montcel C; Carton L; Pelissolo A Curr Psychiatry Rep; 2017 Nov; 19(12):103. PubMed ID: 29110139 [TBL] [Abstract][Full Text] [Related]
16. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature. Wright BM; Eiland EH; Lorenz R Pharmacotherapy; 2013 Mar; 33(3):344-59. PubMed ID: 23456734 [TBL] [Abstract][Full Text] [Related]
17. A literature review of quetiapine for generalized anxiety disorder. Kreys TJ; Phan SV Pharmacotherapy; 2015 Feb; 35(2):175-88. PubMed ID: 25689246 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. Gao K; Muzina D; Gajwani P; Calabrese JR J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818 [TBL] [Abstract][Full Text] [Related]
19. Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study. Karaiskos D; Pappa D; Tzavellas E; Siarkos K; Katirtzoglou E; Papadimitriou GN; Politis A Int J Geriatr Psychiatry; 2013 Jan; 28(1):100-5. PubMed ID: 22431439 [TBL] [Abstract][Full Text] [Related]
20. Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications. Behar E; DiMarco ID; Hekler EB; Mohlman J; Staples AM J Anxiety Disord; 2009 Dec; 23(8):1011-23. PubMed ID: 19700258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]